Both semaglutide and tirzepatide activate GLP-1 pathways and trigger similar metabolic changes, so cold sensitivity is common with both medications
While combining peptides into one syringe can make administration more convenient (fewer injections), improper mixing can: - Reduce their therapeutic potency - Lead to unwanted chemical reactions - Waste the treatment potential of an otherwise powerful therapy The rules of thumb: Peptides that can be mixed: BPC157, TB4, GHK-Cu, CJC/Ipamorelin, Tesamorelin, Semorelin, TA1, Pinealon, Epithalon, Selank Peptides that should not be combined: Semaglutide, Tirzepatide, Retatrutide, Melanotan, VIP, Pentosan Combine separately: NAD+, MOTS-c, SS-31 Have more questions about peptides or precision longevity care
Therefore, as an autoimmune disease, GD can cause systemic immune activation and high levels of inflammatory factors in the circulation, leading to the activation of the HPA axis and hypersecretion of related hormones
* The news published on studies do not represent an official position of ICNS, nor a clinical recommendation.